Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dobutamine During Major Abdominal Surgery
Sponsor: University of Hamburg-Eppendorf
Summary
The PUSH-1 trial is a randomized, single-center pilot trial investigating whether dobutamine administration is feasible in patients having major abdominal surgery.
Official title: Dobutamine During Major Abdominal Surgery: A Randomized Pilot Trial (PUSH-1)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-06-16
Completion Date
2026-04
Last Updated
2025-06-17
Healthy Volunteers
No
Conditions
Interventions
Dobutamine
In patient assigned to dobutamine administration, dobutamine (concentration: 5 mg mL-1) will be administered with an infusion rate of 3 µg kg-1 min-1 (ideal body weight).
Routine care
In patients assigned to routine care, intraoperative hemodynamic management will be in accordance with routine care.
Locations (1)
University Medical Center Hamburg-Eppendorf
Hamburg, Hamburg, Germany